Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Asana BioSciences' ASN-002 shows efficacy in atopic dermatitis in proof-of-concept study

Jan. 5, 2018

FDA approves Dermapace System to treat diabetic foot ulcers

Dec. 29, 2017

FDA accepts Seysara NDA for moderate to severe acne

Dec. 21, 2017

Pilot clinical study of Aclaris Therapeutics' ATI-50002 in vitiligo begins

Dec. 20, 2017

RXI-109 improves revision of hypertrophic scars in phase II trial

Dec. 19, 2017

Phase III trial for PF-04965842 in atopic dermatitis begins

Dec. 15, 2017

BioStem Technologies, University of Miami to conduct preclinical study of BSEM17-115

Dec. 13, 2017

Almirall and Athenex to collaborate on developing KX2-391

Dec. 12, 2017

CCL-20 S64C demonstrates efficacy in IL-23-dependent mouse model of psoriasis

Dec. 11, 2017

Exicure presents novel antisense oligonucleotides targeteing IL-17RA

Dec. 7, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...